We observed the intriguing connection between Meniere's disease (MD) and migraine-related dizziness in our study of a 5-year-old girl. She experienced a six-month struggle with left-sided hearing loss, which evolved into daily bouts of vertigo, headaches, and vomiting, fulfilling the criteria for definite MD.
After implementing a specialized six-week migraine diet and lifestyle plan that included riboflavin and magnesium, we noted a remarkable transformation. The child became symptom-free and achieved nearly normal hearing levels, leading us to consider that MD symptoms might be linked to vestibular migraine triggers.
This suggests that young patients with MD could greatly benefit from lifestyle and dietary adjustments aimed at managing migraine symptoms. While magnesium was part of this regimen, it’s essential to look at it as one component of a broader approach. The results invite further exploration into how dietary interventions may alleviate both cochlear and vestibular symptoms in Meniere's disease.
Read More
We looked into the issue of persistent post-stapedotomy vertigo, or PSV, which can leave patients feeling dizzy for months after ear surgery. Over a span of ten years, we examined cases at a major hospital where patients reported ongoing dizziness for at least three months following their procedure.
Our findings included five patients who struggled with daily vertigo episodes, averaging 53 years old. They were treated with a combination of lifestyle and dietary changes alongside medications like nortriptyline and verapamil. Interestingly, vitamin B2 and magnesium were also part of the regimen.
After starting treatment, we noticed a remarkable turnaround. All five patients experienced a complete resolution of their vertigo over an average period of nine weeks. While magnesium was included in their treatment, we cannot definitively point to its isolated effect on dizziness, as it was used alongside other medications. Overall, our results hint that patients suffering from this type of vertigo might indeed benefit from migraine prophylaxis treatments, where magnesium could play a role, but more research is needed to isolate its impact specifically.
Read More
We observed a striking case involving a 76-year-old woman diagnosed with cervical cancer, who was treated with nedaplatin, a platinum-based chemotherapy drug. Shortly after starting her treatment, she experienced troubling symptoms, including numbness, dizziness, and a noticeable loss of appetite.
Upon investigation, we discovered low levels of calcium and magnesium in her blood, which were likely contributing to her symptoms. Thankfully, after administering intravenous calcium and magnesium, we saw a prompt improvement in both her mineral levels and her symptoms.
The case underscores the importance of monitoring electrolyte levels during chemotherapy treatments, such as nedaplatin. By focusing on these disturbances, healthcare providers can unveil potential diagnoses even when patients present with vague symptoms. Regular follow-ups during anticancer therapies could be crucial in effectively managing side effects such as dizziness.
Read More
Magnesium treatment alleviates dizzinessClinical and genetic analysis of a case of Gitelman syndrome accompanied with Graves disease and adrenocortical adenoma: A case report.
Moderate relevance to magnesium effects
We explored the effects of magnesium treatment in a unique case involving a patient diagnosed with Gitelman syndrome, Graves disease, and an adrenocortical adenoma. The treatment we administered included potassium magnesium aspartate and potassium chloride alongside spironolactone, which collectively aimed to address the patient's symptoms of dizziness and fatigue.
After three months of consistent treatment, we observed notable improvements in the patient’s condition. Their blood potassium and magnesium levels stabilized, and by the sixth day of hospitalization, the symptoms including dizziness, limb weakness, and general fatigue were completely relieved. This correlation between magnesium supplementation and alleviation of dizziness suggests a potential benefit, though it's important to note that the isolated effects of magnesium cannot be fully determined without further study.
During follow-up, the absence of symptom recurrence reinforced our findings, indicating that magnesium may play a role in managing symptoms associated with Gitelman syndrome. While this case does present promising outcomes, we recognize that more rigorous studies are necessary to comprehensively evaluate magnesium's effectiveness in treating dizziness across broader populations.
Read More
Magnesium may reduce dizzinessEffects of nonprescription therapies on vestibular migraine: a questionnaire-based observational study.
Study assesses combined supplement effects.
We aimed to understand how nonprescription therapies, particularly those containing magnesium, can affect symptoms of dizziness in individuals diagnosed with vestibular migraine (VM). In this observational study, we evaluated patients at two tertiary clinics in Sydney over a span of 10 months. Participants were guided on lifestyle changes that support health and were provided with an over-the-counter supplement featuring magnesium along with riboflavin, coenzyme Q10, and feverfew.
After three months of using this supplement, we found significant improvements in dizziness-related symptoms. Participants reported a reduction in their overall symptom severity and frequency, with many expressing positive changes in their quality of life. In fact, approximately half of the patients noticed improvement according to various measurement scales, confirming the potential benefits of the supplement regimen.
While the study indicates a promising relationship between magnesium and dizziness, we should note that it was part of a complex blend of ingredients. This makes it challenging to attribute improved results strictly to magnesium alone. Nevertheless, the findings suggest that nonprescription strategies might play a valuable role in managing VM symptoms.
Read More